Información*
| Nombre | TOMAS RENE PULIDO ZAMUDIO |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | MEDICINA Y CIENCIAS DE LA SALUD |
| Disciplina | MEDICINA INTERNA |
| Especialidad | ENFERMEDADES PULMONARES |
| CVU | 25608 |
| Institución | |
|---|---|
| Dependencia | SIN INFORMACION |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 2 |
| Vigencia | Inicio: 01/01/2025 |
| Fin: 31/12/2029 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2025
- Why Wait for Sick People to Get Sicker? The Paradox of the Treatment of Patients With Pulmonary Arterial Hypertension Pulmonary Circulation
- Pulmonary arterial hypertension in Latin America. The age and comorbidity paradox International Journal of Cardiology Congenital Heart Disease
- 2021
- Macitentan in the Treatment of Pulmonary Arterial Hypertension Future Cardiology
- 2019
- Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension: A Double-Blind, Placebo-Controlled Study. American journal of respiratory and critical care medicine
- Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases. Circulation. Cardiovascular quality and outcomes
- Risk stratification and medical therapy of pulmonary arterial hypertension. The European respiratory journal
- Advances in medical therapy for pulmonary arterial hypertension. Current opinion in cardiology
- Evaluation of Macitentan in Patients With Eisenmenger Syndrome. Circulation
- 2018
- Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial. PloS one
- Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial. American journal of cardiovascular drugs : drugs, devices, and other interventions